Fire Safety Week
March 17, 2025
Catalyzing Discoveries | Revolutionizing Healthcare
Discovery
Transforming the discovery process with advanced technology, delivering innovative breakthroughs with precision and speed.
Development
Accelerating development through collaborative solutions, ensuring efficiency and accuracy at every critical stage.
Manufacture
Effortlessly evolving from research to full-scale production while maintaining rigorous quality controls at every stage.
Who We are
Aryastha Helps You
Scientific Expertise Team
Expert innovators in drug discovery, redefining therapeutic possibilities creatively.
Advanced Technology
Game-changing technology accelerates drug discovery, enabling faster, smarter decisions.
Trusted Partnership
Building lasting partnerships through trust, collaboration, and shared success.
World-Class Laboratory
State-of-the-art lab for precision research, turning scientific ideas into reality.
Latest Events & Updates
Women’s Day Celebrations
March 11, 2025
Makar Sankranti Celebrations
January 11, 2025
Christmas Celebrations
December 25, 2024
Deepavali Celebrations
October 31, 2024
Drug Discovery and Development Services
Aryastha Infrastructure
Comprehensive world-class facility in India
~20,000 SQFT of dedicated R&D center
A powerhouse of innovation, advancing research from discovery to impactful development.
24/7 Analytical & ancillary support
24/7 support at Aryastha ensures seamless progress with real-time research insights.
State of the art analytical instrumentation
Aryastha delivers precision and speed using advanced HPLC and NMR for timely, accurate analysis and purification.
Our services
What We Do
Aryastha’s services and alliances are built on a cutting-edge technology platform, offering a broad range of capabilities throughout the drug discovery process. With a strong track record, experienced scientists, and innovative technology, we provide comprehensive discovery services from target identification to preclinical candidate nomination. Our extensive expertise spans Chemistry, Biology, DMPK, and Pharmacology, supporting both stand-alone and integrated solutions.
Discovery Chemistry
Medicinal chemistry in drug discovery involves the intricate process of conceiving and developing new medicines. While this journey is lengthy, complex, expensive, and risky, the potential benefits for millions of patients with serious illnesses serve as a constant driving force.
Discovery Biology
Aryastha Life Sciences specializes in drug discovery and development services, harnessing the power of established cell line, primary cells from diseased organs, and in vivo models, including syngeneic and cell/tissue-derived systems.
Pre-Clinical DMPK
Aryastha provides a comprehensive range of services encompassing in vitro ADME, toxicity (in vitro ADMET), and in vivo pharmacokinetics (PK), offering rapid evaluations of test articles DMPK properties and toxicity.
Development Services
The journey of a drug substance through medicinal chemistry rarely concludes with an ultimate production route. Scaling a drug substance from milligrams to kilograms entails much more.
Co-Founders & Leadership
Aryastha Co-Founders & Leadership combine unmatched agility and flexibility, continuously driving innovation and scientific excellence to accelerate the delivery of life-changing medicines. Over the years, they have transformed Aryastha into a trusted, one-stop solution for the pharmaceutical and biotechnology industries by addressing critical challenges in drug discovery and development. With their extensive experience, they’ve successfully advanced 6 clinical assets through phases I, II, and III, secured 11 IND approvals, and led over 75 integrated programs.
IP & Confidentiality
IP owned by the client
Restricted role-based access control to ensure IP protection and confidentiality of client programs
Secured IT infrastructure with multi-factor authentication in place to protect against any cyber threats
Business Model & Scalability
Ability to quickly scale-up infrastructure and skilled manpower as per client requirement.
Flexible Business Models
Aryastha Life Sciences Blogs
𝐒𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐰𝐢𝐭𝐡 𝐀𝐫𝐲𝐚𝐬𝐭𝐡𝐚’𝐬 𝐂𝐑𝐂 𝐓𝐮𝐦𝐨𝐫 𝐎𝐫𝐠𝐚𝐧𝐨𝐢𝐝 – a breakthrough in therapeutic development. Our state-of-the-art, pathologically relevant tumor model is developed directly from patient biopsy samples and faithfully replicates tumor heterogeneity, preserving the native tumor epithelial/stromal microenvironment to closely mimic in vivo conditions.
𝑲𝒆𝒚 𝑩𝒆𝒏𝒆𝒇𝒊𝒕𝒔:
𝐇𝐢𝐠𝐡 𝐏𝐫𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐯𝐞 𝐏𝐨𝐰𝐞𝐫
𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡
𝐕𝐞𝐫𝐬𝐚𝐭𝐢𝐥𝐞 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
Use the power of 𝐀𝐫𝐲𝐚𝐬𝐭𝐡𝐚 𝐁𝐢𝐨𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬® to screen your compounds to unlock the next breakthrough
Discover more https://aryastha.com/
Connect With Us : [email protected]
#AryasthaBiosolutions #CancerResearch #TumorOrganoids #DrugDiscovery #Oncology #PrecisionMedicine #Biosolutions #PreclinicalResearch #AryasthaLifeSciences #TranslationalScience #PersonalizedMedicine #TherapeuticDevelopment #Biotech #Pharma #InnovativeMedicine #ClinicalResearch #NextGenTherapeutics #OncologyInnovation #CancerTreatment #Biotechnology
Introducing the Patient Tumor-Derived Breast Cancer Organoid Model 🔬
We are excited to present an advanced and pathologically relevant tumor model that brings us a step closer to precision medicine. Our Patient Tumor-Derived Breast Cancer Organoid Model is created from biopsy samples, accurately replicating intraductal carcinoma with well-formed glandular structures. This model preserves the native tumor epithelial/stromal microenvironment, ensuring it closely mimics in vivo conditions.
Key benefits of this cutting-edge model:
✅ Therapeutic Agnostic: Perfect for testing a wide range of treatments, including immune checkpoint inhibitors, chemotherapeutics, peptides, biologics, and targeted therapies.
✅ High Predictive Power: Excellent for drug screening in a clinically relevant setting.
✅ Patient-Specific Studies: Enables tailored drug response studies for personalized treatment approaches.
✅ High-Throughput Screening: Allows screening for efficacy, PD markers, discovery of responder signatures, and exploration of combination therapies and mechanisms of action.
✅ Subtype Adaptability: Can be customized for specific breast cancer subtypes, genetic profiling, and pathway analysis.
This innovative model is not just a leap in understanding the tumor microenvironment, but it also offers immense potential in advancing drug discovery and cancer treatment. Let’s push the boundaries of precision oncology together!
#AryasthaLifeSciences #CancerResearch #BreastCancer #OrganoidModel #DrugDiscovery #PrecisionMedicine #Biotech #Oncology
𝙋𝙪𝙨𝙝𝙞𝙣𝙜 𝙩𝙝𝙚 𝘽𝙤𝙪𝙣𝙙𝙖𝙧𝙞𝙚𝙨 𝙤𝙛 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙬𝙞𝙩𝙝 𝘼𝙧𝙮𝙖𝙨𝙩𝙝𝙖 𝘽𝙞𝙤𝙨𝙤𝙡𝙪𝙩𝙞𝙤𝙣𝙨®
The 𝘼𝙧𝙮𝙖𝙨𝙩𝙝𝙖 𝙇𝙞𝙛𝙚 𝙎𝙘𝙞𝙚𝙣𝙘𝙚𝙨 scientific team had the privilege of attending the 44th Annual Meeting of the Indian Association for Cancer Research (IACR) and the International Conference on Convergence of Fundamental and Translational Approaches in Cancer Theranostics, held from January 16-18, 2025, in Kolkata.
At this prestigious event, we showcased Aryastha Biosolutions®, our cutting-edge technology platform designed to accelerate drug discovery and development. It was an incredible opportunity to engage with leading researchers, biotech innovators, and pharma experts, demonstrating how our platform empowers oncology R&D with precision-driven insights and advanced computational approaches.
A big thank you to the IACR community for fostering insightful discussions on the future of cancer theranostics and for the opportunity to share how Aryastha Biosolutions® is driving next-gen breakthroughs in oncology drug discovery.
Looking forward to continued collaborations that push the frontiers of science and innovation!
Visit Us : https://aryastha.com/
#AryasthaLifeSciences #CancerResearch #DrugDiscovery #Oncology #Biotech #Pharma #AryasthaBiosolutions® #IACR2025 #TranslationalResearch #PrecisionOncology #Theranostics #ClinicalResearch #PatientDerivedModels #Organoids #BiomedicalInnovation #PharmaceuticalResearch #NextGenTherapeutics #OncologyBreakthroughs #CancerTherapeutics #IntegratedDrugDevelopment #HumanizedModels
Biosolutions® by Aryastha Life Sciences: Revolutionizing Drug Discovery & Development
Aryastha Biosolutions®, developed by the scientists at Aryastha Life Sciences Pvt. Ltd., is a groundbreaking platform that accelerates drug discovery by integrating cutting-edge AI-driven analytics with clinically validated patient samples and multi-omics insights.
Designed to optimize the drug development process, Aryastha Biosolutions® enhances efficiency, accelerates decision-making, and reduces R&D costs, significantly boosting clinical success rates. The platform leverages humanized organoids and iPSC-derived models, creating highly predictive disease models that enable more accurate assessments of drug efficacy and toxicity. Powered by AI and translational data, Aryastha Biosolutions® identifies novel biomarkers for patient stratification and optimizes lead molecules. Aryastha Biosolutions® empowers biotech and pharmaceutical companies to overcome complex biological challenges, validate disease pathways, and fast-track the development of new chemical entities with unparalleled precision and innovation.
https://aryastha.com/
#AryasthaBiosolutions® #DrugDiscovery #AryasthaLifeSciences #DrugDevelopment #TranslationalResearch #PrecisionMedicine #BiotechInnovation #PharmaceuticalResearch #Organoids #AIinHealthcare #ClinicalResearch #PatientDerivedModels #Biotech #LifeSciences #InnovativeHealthcare #BiomedicalResearch #NextGenTherapeutics #PharmaTech #ResearchAndDevelopment #HealthcareInnovation #AryasthaLifeSciences #Humanized #iPSCModels #Biosolutions #Preclinical #Clinical
